Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Shareholder Information

Oxurion is listed on Euronext Brussels under the symbol OXUR.

As of 31 December 2020, Oxurion has a total number of 38,291,950 outstanding shares and a total number of 1,043,800 outstanding subscription rights, of which 893,800 are accepted unexercised, and 150,000 are to be assigned

KBC Bank is acting as the paying agent. The paying agent will not charge shareholders with respect to payments of dividends, the exercise of subscription rights and other events concerning Oxurion shares. Shareholders should inform themselves about the amounts that other financial intermediaries may charge in connection with paying agency services.

View Shareholders History of Capital


Extraordinary Shareholders Meeting 2021
  • Convening notice of the extraordinary shareholders' meeting on August 13, 2021 - view document
  • Proxy form for the extraordinary shareholders' meeting of August 13, 2021 - view document
  • Shareholders' rights EGM meeting of August 13, 2021 - view document
  • Oxurion Remuneration Policy 2021 - view document
  • Tom Graney – Bio - view document 
Annual Shareholders Meeting 2021
  • Convocation of annual shareholders' meeting on May 4, 2021 - view document
  • Proxy form for the annual shareholders' meeting of May 4, 2021 - view document
  • Shareholders' rights for AGM of 4 May 2021 - view document
  • Minutes of the annual shareholder's meeting on May 4, 2021 - view document
  • Statutory accounts for the financial year 2020 - view document
  • Annual report - financial information 2020 - view document
  • Annual Report of the Board of Directors on the consolidated financial statements for the FY 2020 - view document
  • Annual Report of the Board of Directors on the statutory accounts for the FY 2020 - view document
  • Auditor's report in relation to the consolidated accounts for the financial year 2020 - view document
  • Auditor's report in relation to the statutory accounts for the financial year 2020 - view document
  • Oxurion - Board Remuneration Policy 2021 - view document

Archive